Cargando…

Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials

BACKGROUND/OBJECTIVES: In the absence of consistent clinical evidence, there are concerns that fructose contributes to non-alcoholic fatty liver disease (NAFLD). To determine the effect of fructose on markers of NAFLD, we conducted a systematic review and meta-analysis of controlled feeding trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, S, Sievenpiper, J L, de Souza, R J, Cozma, A I, Mirrahimi, A, Carleton, A J, Ha, V, Di Buono, M, Jenkins, A L, Leiter, L A, Wolever, T M S, Don-Wauchope, A C, Beyene, J, Kendall, C W C, Jenkins, D J A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975811/
https://www.ncbi.nlm.nih.gov/pubmed/24569542
http://dx.doi.org/10.1038/ejcn.2014.8
_version_ 1782310192736632832
author Chiu, S
Sievenpiper, J L
de Souza, R J
Cozma, A I
Mirrahimi, A
Carleton, A J
Ha, V
Di Buono, M
Jenkins, A L
Leiter, L A
Wolever, T M S
Don-Wauchope, A C
Beyene, J
Kendall, C W C
Jenkins, D J A
author_facet Chiu, S
Sievenpiper, J L
de Souza, R J
Cozma, A I
Mirrahimi, A
Carleton, A J
Ha, V
Di Buono, M
Jenkins, A L
Leiter, L A
Wolever, T M S
Don-Wauchope, A C
Beyene, J
Kendall, C W C
Jenkins, D J A
author_sort Chiu, S
collection PubMed
description BACKGROUND/OBJECTIVES: In the absence of consistent clinical evidence, there are concerns that fructose contributes to non-alcoholic fatty liver disease (NAFLD). To determine the effect of fructose on markers of NAFLD, we conducted a systematic review and meta-analysis of controlled feeding trials. SUBJECTS/METHODS: We searched MEDLINE, EMBASE, CINAHL and the Cochrane Library (through 3 September 2013). We included relevant trials that involved a follow-up of ⩾7 days. Two reviewers independently extracted relevant data. Data were pooled by the generic inverse variance method using random effects models and expressed as standardized mean difference (SMD) for intrahepatocellular lipids (IHCL) and mean difference (MD) for alanine aminotransferase (ALT). Inter-study heterogeneity was assessed (Cochran Q statistic) and quantified (I(2) statistic). RESULTS: Eligibility criteria were met by eight reports containing 13 trials in 260 healthy participants: seven isocaloric trials, in which fructose was exchanged isocalorically for other carbohydrates, and six hypercaloric trials, in which the diet was supplemented with excess energy (+21–35% energy) from high-dose fructose (+104–220 g/day). Although there was no effect of fructose in isocaloric trials, fructose in hypercaloric trials increased both IHCL (SMD=0.45 (95% confidence interval (CI): 0.18, 0.72)) and ALT (MD=4.94 U/l (95% CI: 0.03, 9.85)). LIMITATIONS: Few trials were available for inclusion, most of which were small, short (⩽4 weeks), and of poor quality. CONCLUSIONS: Isocaloric exchange of fructose for other carbohydrates does not induce NAFLD changes in healthy participants. Fructose providing excess energy at extreme doses, however, does raise IHCL and ALT, an effect that may be more attributable to excess energy than fructose. Larger, longer and higher-quality trials of the effect of fructose on histopathological NAFLD changes are required.
format Online
Article
Text
id pubmed-3975811
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39758112014-04-07 Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials Chiu, S Sievenpiper, J L de Souza, R J Cozma, A I Mirrahimi, A Carleton, A J Ha, V Di Buono, M Jenkins, A L Leiter, L A Wolever, T M S Don-Wauchope, A C Beyene, J Kendall, C W C Jenkins, D J A Eur J Clin Nutr Review BACKGROUND/OBJECTIVES: In the absence of consistent clinical evidence, there are concerns that fructose contributes to non-alcoholic fatty liver disease (NAFLD). To determine the effect of fructose on markers of NAFLD, we conducted a systematic review and meta-analysis of controlled feeding trials. SUBJECTS/METHODS: We searched MEDLINE, EMBASE, CINAHL and the Cochrane Library (through 3 September 2013). We included relevant trials that involved a follow-up of ⩾7 days. Two reviewers independently extracted relevant data. Data were pooled by the generic inverse variance method using random effects models and expressed as standardized mean difference (SMD) for intrahepatocellular lipids (IHCL) and mean difference (MD) for alanine aminotransferase (ALT). Inter-study heterogeneity was assessed (Cochran Q statistic) and quantified (I(2) statistic). RESULTS: Eligibility criteria were met by eight reports containing 13 trials in 260 healthy participants: seven isocaloric trials, in which fructose was exchanged isocalorically for other carbohydrates, and six hypercaloric trials, in which the diet was supplemented with excess energy (+21–35% energy) from high-dose fructose (+104–220 g/day). Although there was no effect of fructose in isocaloric trials, fructose in hypercaloric trials increased both IHCL (SMD=0.45 (95% confidence interval (CI): 0.18, 0.72)) and ALT (MD=4.94 U/l (95% CI: 0.03, 9.85)). LIMITATIONS: Few trials were available for inclusion, most of which were small, short (⩽4 weeks), and of poor quality. CONCLUSIONS: Isocaloric exchange of fructose for other carbohydrates does not induce NAFLD changes in healthy participants. Fructose providing excess energy at extreme doses, however, does raise IHCL and ALT, an effect that may be more attributable to excess energy than fructose. Larger, longer and higher-quality trials of the effect of fructose on histopathological NAFLD changes are required. Nature Publishing Group 2014-04 2014-02-26 /pmc/articles/PMC3975811/ /pubmed/24569542 http://dx.doi.org/10.1038/ejcn.2014.8 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Review
Chiu, S
Sievenpiper, J L
de Souza, R J
Cozma, A I
Mirrahimi, A
Carleton, A J
Ha, V
Di Buono, M
Jenkins, A L
Leiter, L A
Wolever, T M S
Don-Wauchope, A C
Beyene, J
Kendall, C W C
Jenkins, D J A
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
title Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
title_full Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
title_fullStr Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
title_full_unstemmed Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
title_short Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
title_sort effect of fructose on markers of non-alcoholic fatty liver disease (nafld): a systematic review and meta-analysis of controlled feeding trials
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975811/
https://www.ncbi.nlm.nih.gov/pubmed/24569542
http://dx.doi.org/10.1038/ejcn.2014.8
work_keys_str_mv AT chius effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT sievenpiperjl effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT desouzarj effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT cozmaai effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT mirrahimia effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT carletonaj effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT hav effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT dibuonom effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT jenkinsal effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT leiterla effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT wolevertms effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT donwauchopeac effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT beyenej effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT kendallcwc effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials
AT jenkinsdja effectoffructoseonmarkersofnonalcoholicfattyliverdiseasenafldasystematicreviewandmetaanalysisofcontrolledfeedingtrials